https://www.selleckchem.com/pr....oducts/Rapamycin.htm
ONCOLOGY sat down with Sagar Lonial, MD, professor and chair of Hematology and Medical Oncology at the Emory University School of Medicine and chief medical officer at Emory's Winship Cancer Institute, to discuss the FDA approval of the antibody-drug conjugate belantamab mafodotin, along with other BCMA-targeting agents for patients with multiple myeloma.As long-term survival rates continue to rise in adolescents and young adults receiving a diagnosis of cancer, the focus of oncologic care has shifted from survival to both survival an
Synes godt om
Kommentar
Del
